Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000435576 | SCV000518795 | likely benign | not specified | 2017-12-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001511158 | SCV001718353 | benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502505 | SCV002807155 | likely benign | Mitochondrial complex II deficiency, nuclear type 1; Dilated cardiomyopathy 1GG; Paragangliomas 5; Neurodegeneration with ataxia and late-onset optic atrophy | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001528986 | SCV001741673 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000435576 | SCV001807050 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001528986 | SCV001955950 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001528986 | SCV002036829 | likely benign | not provided | no assertion criteria provided | clinical testing |